Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Harte Hanks Inc (HHS) A Good Stock To Buy?

Page 1 of 2

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant out-performance. These stocks have been on a tear since the end of June, outperforming large-cap index funds by more than 10 percentage points. That’s why we pay special attention to hedge fund activity in these stocks.

Harte Hanks Inc (NYSE:HHS) has experienced a decrease in enthusiasm from smart money in recent months. There were 9 hedge funds in our database with HHS positions at the end of the last quarter. At the end of this article we will also compare HHS to other stocks including CARDIOME PHARMA CORP (NASDAQ:CRME), Destination Maternity Corp (NASDAQ:DEST), and Digirad Corporation (NASDAQ:DRAD) to get a better sense of its popularity.

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Maxx-Studio/Shutterstock.com

How have hedgies been trading Harte Hanks Inc (NYSE:HHS)?

At Q3’s end, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, down by 31% from one quarter earlier. The graph below displays the number of hedge funds with bullish position in HHS over the last 5 quarters. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were upping their holdings significantly (or already accumulated large positions).

HedgeFundSentimentChart

When looking at the institutional investors followed by Insider Monkey, Renaissance Technologies, one of the largest hedge funds in the world, holds the largest position in Harte Hanks Inc (NYSE:HHS). Renaissance Technologies has a $2 million position in the stock. Sitting at the No. 2 spot is Chuck Royce of Royce & Associates holding a $1.4 million position. Other professional money managers that hold long positions encompass Gregory Fraser, Rudolph Kluiber, and Timothy Krochuk’s GRT Capital Partners, Israel Englander’s Millennium Management and John Overdeck and David Siegel’s Two Sigma Advisors. We should note that GRT Capital Partners is among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2